Medicalgorithmics Announces Key Partnership in Strategic Expansion of Cardiac Diagnostic Services
Medicalgorithmics, an AI-focused MedTech company listed on the sWIG80 index of the Polish Stock Exchange, announces a significant partnership with a European leader in global cardiac diagnostic services. Medicalgorithmics will provide a comprehensive technology platform for cardiac arrhythmia diagnosis, utilizing its proprietary artificial intelligence (AI) algorithms. This system has already been successfully commercialized in 22 countries, with regulatory clearances enabling entry into over 50 countries.